CDMOs must consider challenges associated with the complexity of contract pharmaceutical manufacturing when approaching digitalization projects.
Kai Vogt
Advertisement
Kai Vogt is senior vice-president Corporate Development, Legal and Compliance, Information Technology at Vetter Pharma.
Articles by Kai Vogt
Advertisement
Latest Updated Articles
- Digitalization: A CDMO’s Perspective
February 15th 2020
Advertisement
Advertisement
Trending on BioPharm International
1
Nuravax Alzheimer Vaccine AV-1959R Earns FDA Fast Track Designation
2
Nano24's Inhaled EXO-CD24 Cuts ARDS Mortality in Phase 2b Trial
3
The BioPharm Brief: Lung Injury Survival, Alzheimer Prevention, and Longer Dosing Intervals
4
Roche, Hansoh Sign Second ADC Pact Covering Preclinical and Roche-Selected Targets
5